Parker, C. T. A., Liu, V. Y., Mendes, L., Grist, E., Yamashita, R., Croucher, D. C., Sachdeva, A., Murphy, L., Huang, H., Jones, R. J., Gillessen, S., Parker, C. C., Berney, D., Tran, P. T., Spratt, D. E., Parmar, M. K. B., Clarke, N. W., Brown, L. C., James, N. D., Attard, G. (2025). Multimodal artificial intelligence (MMAI) model to identify benefit from 2nd-generation androgen receptor pathway inhibitors (ARPI) in high-risk non-metastatic prostate cancer patients from STAMPEDE.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5001